Team:Caltech
From 2008.igem.org
(Difference between revisions)
Line 13: | Line 13: | ||
[[Image:Gut_flora_color.png|right|thumb|200px|Engineered gut flora]] | [[Image:Gut_flora_color.png|right|thumb|200px|Engineered gut flora]] | ||
We aim to engineer a probiotic bacterium to improve its medical applications. Our work focuses on four main areas: (1) pathogen defense, either by expression of pathogen-specific bacteriophage or by targeted bursts of reactive oxygen species; (2) vitamin over-expression and delivery; (3) treatment of lactose intolerance, by preferentially metabolizing lactose and funneling it to vitamin production; and (4) regulation of these three treatment functions to produce subpopulations specialized for each function. | We aim to engineer a probiotic bacterium to improve its medical applications. Our work focuses on four main areas: (1) pathogen defense, either by expression of pathogen-specific bacteriophage or by targeted bursts of reactive oxygen species; (2) vitamin over-expression and delivery; (3) treatment of lactose intolerance, by preferentially metabolizing lactose and funneling it to vitamin production; and (4) regulation of these three treatment functions to produce subpopulations specialized for each function. | ||
+ | {{clear}} | ||
==Why engineer gut microbes?== | ==Why engineer gut microbes?== | ||
Line 21: | Line 22: | ||
===Nissle 1917: Probiotic, commercially available ''E. coli''=== | ===Nissle 1917: Probiotic, commercially available ''E. coli''=== | ||
+ | [[Image:packshot_mutaflor.jpg|thumb|Mutaflor - q commercially available probiotic ''E. coli'' strain Nissle 1917]] | ||
+ | |||
+ | {{clear}} | ||
For more details, please see our [[Team:Caltech/Project|project]] page. | For more details, please see our [[Team:Caltech/Project|project]] page. | ||
|} | |} |
Revision as of 21:06, 22 August 2008
People
|
{{{Content}}} |
</div>
The big ideaWe aim to engineer a probiotic bacterium to improve its medical applications. Our work focuses on four main areas: (1) pathogen defense, either by expression of pathogen-specific bacteriophage or by targeted bursts of reactive oxygen species; (2) vitamin over-expression and delivery; (3) treatment of lactose intolerance, by preferentially metabolizing lactose and funneling it to vitamin production; and (4) regulation of these three treatment functions to produce subpopulations specialized for each function. Why engineer gut microbes?The large intestine: an ideal bioreactorProbiotic bacteria and other natural examplesNissle 1917: Probiotic, commercially available E. coliFor more details, please see our project page. |